Emerging Infectious Diseases (Dec 2023)

Invasive Nocardia Infections across Distinct Geographic Regions, United States

  • Simran Gupta,
  • Leah M. Grant,
  • Harry R. Powers,
  • Kathryn E. Kimes,
  • Ahmed Hamdi,
  • Richard J. Butterfield,
  • Juan Gea-Banacloche,
  • Prakhar Vijayvargiya,
  • D. Jane Hata,
  • Diana M. Meza Villegas,
  • Adrian C. Dumitrascu,
  • Dana M. Harris,
  • Razvan M. Chirila,
  • Nan Zhang,
  • Raymund R. Razonable,
  • Shimon Kusne,
  • Salvador Alvarez,
  • Holenarasipur R. Vikram

DOI
https://doi.org/10.3201/eid2912.230673
Journal volume & issue
Vol. 29, no. 12
pp. 2417 – 2425

Abstract

Read online

We reviewed invasive Nocardia infections in 3 noncontiguous geographic areas in the United States during 2011–2018. Among 268 patients with invasive nocardiosis, 48.2% were from Minnesota, 32.4% from Arizona, and 19.4% from Florida. Predominant species were N. nova complex in Minnesota (33.4%), N. cyriacigeorgica in Arizona (41.4%), and N. brasiliensis in Florida (17.3%). Transplant recipients accounted for 82/268 (30.6%) patients overall: 14 (10.9%) in Minnesota, 35 (40.2%) in Arizona, and 33 (63.5%) in Florida. Manifestations included isolated pulmonary nocardiosis among 73.2% of transplant and 84.4% of non–transplant patients and central nervous system involvement among 12.2% of transplant and 3.2% of non–transplant patients. N. farcinica (20.7%) and N. cyriacigeorgica (19.5%) were the most common isolates among transplant recipients and N. cyriacigeorgica (38.0%), N. nova complex (23.7%), and N. farcinica (16.1%) among non–transplant patients. Overall antimicrobial susceptibilities were similar across the 3 study sites.

Keywords